Peter Attia· MD
the reduction was not enormous right so it was you know it was a reasonable reduction I believe it was about a 15% relative reduction
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the reduction was not enormous right so it was you know it was a reasonable reduction I believe it was about a 15% relative reduction
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
they actually found that at a median followup of just under four years the incidents of Mace major adverse cardiac event so remember non-fatal Mi stroke or death from either of those things was lower in the treatment group than in the placebo group